In addition, Tofacitinib has been shown to reduce the T cell stimulatory capacity of human Mo-DC in healthy subjects (30), however the effect of JAK/STAT inhibition on Mo-DC differentiation and function in inflammatory arthritis, such as RA and PsA remains to be elucidated. Here, SOAT1 is linked to rheumatoid arthritis.